Languita, Estelita .

HRN: 11-23-15  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/23/2024
METRONIDAZOLE 500MG (TAB)
07/23/2024
07/30/2024
PO
500mg Tab
TID
S/p NSVD; Thickly MSAF
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: